1. Home
  2. ZLAB vs NMIH Comparison

ZLAB vs NMIH Comparison

Compare ZLAB & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • NMIH
  • Stock Information
  • Founded
  • ZLAB 2013
  • NMIH 2011
  • Country
  • ZLAB China
  • NMIH United States
  • Employees
  • ZLAB N/A
  • NMIH N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • NMIH Property-Casualty Insurers
  • Sector
  • ZLAB Health Care
  • NMIH Finance
  • Exchange
  • ZLAB Nasdaq
  • NMIH Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • NMIH 2.9B
  • IPO Year
  • ZLAB 2017
  • NMIH 2013
  • Fundamental
  • Price
  • ZLAB $32.91
  • NMIH $36.14
  • Analyst Decision
  • ZLAB Buy
  • NMIH Buy
  • Analyst Count
  • ZLAB 6
  • NMIH 6
  • Target Price
  • ZLAB $57.22
  • NMIH $42.33
  • AVG Volume (30 Days)
  • ZLAB 725.2K
  • NMIH 386.9K
  • Earning Date
  • ZLAB 11-11-2025
  • NMIH 11-05-2025
  • Dividend Yield
  • ZLAB N/A
  • NMIH N/A
  • EPS Growth
  • ZLAB N/A
  • NMIH 11.30
  • EPS
  • ZLAB N/A
  • NMIH 4.71
  • Revenue
  • ZLAB $427,799,000.00
  • NMIH $679,621,000.00
  • Revenue This Year
  • ZLAB $41.60
  • NMIH N/A
  • Revenue Next Year
  • ZLAB $53.42
  • NMIH $5.15
  • P/E Ratio
  • ZLAB N/A
  • NMIH $7.68
  • Revenue Growth
  • ZLAB 32.56
  • NMIH 9.99
  • 52 Week Low
  • ZLAB $23.70
  • NMIH $31.90
  • 52 Week High
  • ZLAB $44.34
  • NMIH $43.20
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.59
  • NMIH 28.07
  • Support Level
  • ZLAB $33.76
  • NMIH $38.68
  • Resistance Level
  • ZLAB $34.72
  • NMIH $37.61
  • Average True Range (ATR)
  • ZLAB 0.86
  • NMIH 0.81
  • MACD
  • ZLAB 0.20
  • NMIH -0.33
  • Stochastic Oscillator
  • ZLAB 51.19
  • NMIH 2.29

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

Share on Social Networks: